参考文献/References:
［参 考 文 献］
［1］ Drenth JP, Chrispijn M, Nagorney DM, et al. Medical and surgical treatment options for polycystic liver disease［J］. Hepatology, 2010, 52: 2223- 2230.
［2］ Van Keimpema L, De Koning DB, Van Hoek B, et al. Patients with isolated polycystic liver disease referred to liver centres: clinicalcharacterization of 137 cases［J］. Liver Int, 2011, 31: 92- 98.
［3］ Everson GT, Helmke SM, Doctor B. Advances in management of polycystic liver disease［J］. Expert Rev Gastroenterol Hepatol, 2008, 2: 563- 576.
［4］ Abu- Wasel B, Walsh C, Keough V, et al. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases［J］. World J Gastroenterol, 2013, 19: 5775- 5786.
［5］ Bistritz L, Tamboli C, Bigam D, et al. Polycystic liver disease: Experience at a teaching hospital［J］. Am J Gastroenterol, 2005, 100: 2212- 2217.
［6］ Qian Q, Li AR, King BF, et al. Clinical profile of autosomal dominant polycystic liver disease［J］. Hepatology, 2003, 37: 164- 171.
［7］ 阎洁羽， 段 峰， 王茂强. 选择性肝动脉栓塞治疗多囊肝的相关研究［J］． 介入放射学杂志， 2012， 21： 1054- 1058．
［8］ Takei R, Ubara Y, Hoshino J, et al. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease［J］. Am J Kidney Dis, 2007, 49: 744- 752.
［9］ Ubara Y, Takei R, Hoshino J, et al. Intravascular embolization therapy in a patient with an enlarged polycystic liver［J］. Am J Kidney Dis, 2004, 43: 733- 738.
［10］ 靳 松， 崔 凯， 孙自强， 等． 多囊肝临床研究进展［J］． 国际外科学杂志， 2013， 40： 264- 267．
［11］ Ubara Y. New therapeutic option for autosomal dominant poly- cystic kidney disease patients with enlarged kidney and liver［J］. Ther Apher Dial, 2006, 10: 333- 341.
［12］ Park HC, Kim CW, Ro H, et al. Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients［J］. J Korean Med Sci, 2009, 24: 57- 61.
［13］ Wang MQ, Duan F, Liu FY, et al. Treatment of symptomatic polycystic liver disease: transcatheter super- selective hepatic arterial embolization using a mixture of NBCA and iodized oil［J］. Abdom Imaging, 2013, 38: 465- 473.
［14］ 阎洁羽， 段 峰， 王茂强， 等． 超选择性肝动脉栓塞术治疗多囊肝的初步临床研究［J］． 中华放射学杂志， 2012， 46： 1014- 1018．
［15］ Yamamoto A, Imai S, Kobatake M, et al. Evaluation of tris- acryl gelatin microsphere embolization with monochromatic X rays: comparison with polyvinyl alcohol particles［J］. J Vasc Interv Radiol, 2006, 17: 1797- 1802.
［16］ Bendszus M, Klein R, Burger R, et al. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas［J］. AJNR Am J Neuroradiol, 2000, 21: 255- 261.
［17］ Yu SC, Lok I, Ho SS, et al. Comparison of clinical outcomes of tris- acryl microspheres versus polyvinyl alcohol microspheres for uterine artery embolization for leiomyomas: results of a randomized trial［J］. J Vasc Interv Radiol, 2011, 22: 1229-1235.
［18］ 栾韶亮， 郭 伟， 陈 毅， 等． 肝动脉栓塞治疗症状性多囊肝临床疗效初步分析［J］． 山西医科大学学报， 2014， 45： 404- 406．
相似文献/References:
[1]唐军,明德国,刘作勤,等.脑动静脉畸形的血管内栓塞治疗[J].介入放射学杂志,2000,(03):144.
[2]王兴华,朱汉洲,李立.腹部手术后消化道出血的介入诊断与治疗[J].介入放射学杂志,2000,(04):240.
[3]王仲朴,王茂强,吴朝阳.经导管子宫动脉栓塞治疗症状性子宫平滑肌瘤的初步经验[J].介入放射学杂志,2000,(04):210.
[4]陈年根,程国勤,周士福,等.肾血管平滑肌脂肪瘤的血管造影表现及栓塞治疗[J].介入放射学杂志,1997,(01):30.
[5]刘福全,梁君,周经志,等.肝、脾及咽部血管瘤的介入治疗[J].介入放射学杂志,1997,(03):142.
[6]高中度,茅爱武,邵维城,等.动脉灌注化疗并栓塞治疗中晚期恶性肿瘤935例临床疗效及并发症分析[J].介入放射学杂志,1998,(03):151.
[7]李明华,陈君彦,顾斌贤,等.颅内动脉瘤可解脱弹簧栓塞治疗——附28例分析[J].介入放射学杂志,1998,(04):194.
[8]陈君彦,方淳,李明华.肢体深静脉血栓形成215例分析[J].介入放射学杂志,1999,(01):12.
[9]朱景伟,刘卫东,范一木,等.经眼上静脉途径栓塞治疗自发性海绵窦硬膜动静脉瘘[J].介入放射学杂志,1999,(02):0.
[10]许奕,刘建民,周晓平,等.电解可脱卸弹簧圈栓塞颅内动脉瘤[J].介入放射学杂志,1999,(02):5.